NASDAQ:NBRV
Nabriva Therapeutics plc
- Stock
Last Close
1.41
31/07 20:00
Market Cap
4.55M
Beta: 1.55
Volume Today
706.54K
Avg: 12.53K
PE Ratio
−0.08
PFCF: −0.17
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
net income | 15.48M - | -16.27M 205.11% | -31.39M 92.91% | -54.89M 74.88% | -74.36M 35.46% | -114.78M 54.37% | -82.76M 27.89% | -69.48M 16.05% | -49.45M 28.83% | -57.19M 15.64% | |
depreciation and amortization | 197.46K - | 152.00K 23.02% | 150.88K 0.74% | 233K 54.43% | 432K 85.41% | 510K 18.06% | 770K 50.98% | 820K 6.49% | 637K 22.32% | 217K 65.93% | |
deferred income tax | 1.07M - | 87.55K 91.83% | -438.41K 600.75% | -794K 81.11% | 1.41M 277.58% | 2.76M - | |||||
stock based compensation | 29.00K - | -419.52K 1,546.74% | -604.60K 44.11% | 2.54M 520.94% | 5.73M 125.23% | 5.15M 10.08% | 9.75M 89.13% | 5.22M 46.46% | 3.29M 36.94% | 1.97M 40.23% | |
change in working capital | 2.01M - | 15.81K 99.21% | 2.75M 17,280.24% | 3.60M 31.07% | -1.33M 136.82% | 4.03M 403.77% | -195K 104.84% | -11.39M 5,741.54% | -14.86M 30.43% | 13.73M 192.43% | |
accounts receivables | 3.62M - | -3.13M - | -1.93M 38.34% | 2.58M - | -5.89M 328.00% | -8.12M 37.88% | 9.02M 211.06% | ||||
inventory | -0.00 - | 5.91M 590,183,267,803,171.25% | -682K - | -5.14M 653.81% | -8.69M 68.96% | 4.83M 155.64% | |||||
accounts payables | -1.61M - | 644.49K 139.96% | 5.95M 823.35% | -383K 106.44% | 2.58M 774.93% | -2.97M 214.85% | 1.31M 144.12% | -1.81M 238.40% | 1.58M 187.20% | 1.09M 30.87% | |
other working capital | 0.00 - | -628.68K 270,015,332,948,014,048% | -69.97K 88.87% | 5.92M 8,554.89% | -3.91M 166.11% | 7.00M 278.91% | -3.40M 148.66% | 1.45M 142.58% | 365K 74.83% | -1.21M 430.96% | |
other non cash items | -23.94M - | 5.48M 122.91% | 7.17M 30.78% | -16K 100.22% | -1.24M 7,650% | 32.37M 2,710.08% | 549K 98.30% | 748K 36.25% | 822K 9.89% | 4.56M 454.38% | |
net cash provided by operating activities | -5.18M - | -10.53M 103.42% | -21.75M 106.58% | -49.32M 126.72% | -69.35M 40.61% | -72.72M 4.87% | -71.89M 1.14% | -71.33M 0.78% | -59.56M 16.51% | -36.71M 38.36% | |
investments in property plant and equipment | -33.14K - | -82.69K 149.51% | -164.00K 98.33% | -603K 267.69% | -1.17M 94.53% | -229K 80.48% | -61K 73.36% | -113K 85.25% | -25K 77.88% | -211K 744% | |
acquisitions net | -4.26M - | ||||||||||
purchases of investments | -75.37M - | -57.05M 24.31% | -30K 99.95% | -115K 283.33% | |||||||
sales maturities of investments | 3.45M - | 81M - | 50.95M 37.10% | 4.26M 91.64% | |||||||
other investing activites | 0.00 - | 2.43K 522,273,371,286,778.13% | 2K - | -4.26M 213,100% | 392K 109.20% | -161K 141.07% | -56K 65.22% | -52K 7.14% | |||
net cash used for investing activites | 3.42M - | -80.26K 102.35% | -75.54M 94,016.82% | 23.35M 130.92% | 49.75M 113.04% | -4.60M 109.25% | 331K 107.19% | -274K 182.78% | -81K 70.44% | -263K 224.69% | |
debt repayment | -805.05K - | -2.13M 164.33% | -7.27M 241.86% | -30M - | -2.92M - | ||||||
common stock issued | 149.36M - | 24.82M 83.38% | 80M 222.29% | 50M 37.50% | 20.14M 59.72% | 53.46M 165.47% | 27.91M 47.79% | 2.12M 92.39% | |||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 2.21M - | 10.91M 393.55% | -10.12M 192.78% | -2.52M 75.10% | -7.78M 208.65% | 42.92M 651.64% | 35.94M 16.28% | 3.46M 90.36% | 38.45M 1,010.13% | 2.65M 93.11% | |
net cash used provided by financing activities | 1.41M - | 8.78M 524.82% | 131.96M 1,402.40% | 22.30M 83.10% | 72.22M 223.84% | 92.92M 28.67% | 56.08M 39.65% | 26.92M 51.99% | 66.37M 146.49% | 1.85M 97.21% | |
effect of forex changes on cash | -21.89K - | 4.37K 119.98% | 1.37M - | -362K 126.40% | -106K 70.72% | -140K 32.08% | -484K 245.71% | -174K 64.05% | |||
net change in cash | -350.74K - | -1.85M 427.33% | 34.67M 1,974.25% | -3.67M 110.58% | 53.99M 1,571.95% | 15.23M 71.78% | -15.59M 202.35% | -44.82M 187.46% | 6.24M 113.93% | -35.30M 665.29% | |
cash at beginning of period | 4.90M - | 4.00M 18.25% | 1.94M 51.64% | 36.45M 1,783.37% | 32.78M 10.06% | 86.77M 164.72% | 102.00M 17.56% | 86.41M 15.29% | 41.59M 51.87% | 47.83M 15.01% | |
cash at end of period | 4.54M - | 2.15M 52.64% | 36.60M 1,600.50% | 32.78M 10.44% | 86.77M 164.72% | 102.00M 17.56% | 86.41M 15.29% | 41.59M 51.87% | 47.83M 15.01% | 12.54M 73.79% | |
operating cash flow | -5.18M - | -10.53M 103.42% | -21.75M 106.58% | -49.32M 126.72% | -69.35M 40.61% | -72.72M 4.87% | -71.89M 1.14% | -71.33M 0.78% | -59.56M 16.51% | -36.71M 38.36% | |
capital expenditure | -33.14K - | -82.69K 149.51% | -164.00K 98.33% | -603K 267.69% | -1.17M 94.53% | -229K 80.48% | -61K 73.36% | -113K 85.25% | -25K 77.88% | -211K 744% | |
free cash flow | -5.21M - | -10.61M 103.71% | -21.92M 106.52% | -49.92M 127.77% | -70.52M 41.26% | -72.95M 3.45% | -71.95M 1.37% | -71.44M 0.71% | -59.58M 16.60% | -36.92M 38.03% |
All numbers in USD (except ratios and percentages)